Literature DB >> 18157169

Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation.

S Tsang1, S Wu, J Liu, T M Wong.   

Abstract

BACKGROUND AND
PURPOSE: Testosterone alleviates symptoms in patients with ischaemic heart disease. Androgen receptors are present in the heart, and testosterone upregulates gene expression of cardiac beta(1)-adrenoceptors. We hypothesize that testosterone may confer cardioprotection by interacting with adrenoceptors. EXPERIMENTAL APPROACH: In isolated perfused hearts and ventricular myocytes from orchidectomized rats without or with testosterone (200 microg/100 g) replacement, we first determined the effect of ischaemia/reperfusion in the presence of noradrenaline (10(-7) M). Then we determined the contribution of interactions between testosterone and alpha(1)- or beta(1)-adrenoceptors in cardiac injury/protection (infarct size, release of lactate dehydrogenase, viability of myocytes, recovery of contractile function and incidence of arrhythmias) upon ischaemia/reperfusion by pharmacological manipulation using selective adrenoceptor agonists (alpha(1)-adrenoceptor agonist: phenylephrine 10(-6) M; non-selective beta-adrenoceptor agonist: isoprenaline 10(-7) M) and antagonists (alpha(1): prazosin or benoxathian 10(-6) M; beta(1): CGP 20712A 5 x 10(-7) M). We also determined the expression of alpha(1) and beta(1)-adrenoceptor in the hearts from rats with and without testosterone. KEY
RESULTS: Testosterone reduced injury induced by ischaemia/reperfusion and noradrenaline. This was achieved by enhancing the beneficial effect of alpha(1)-adrenoceptor stimulation, which was greater than the deleterious effect of beta(1)-adrenoceptor stimulation (also enhanced by testosterone). The effects of testosterone were abolished or attenuated by blockade of androgen receptors. Testosterone also enhanced the expression of alpha(1A) and beta(1)-adrenoceptor. CONCLUSIONS AND IMPLICATIONS: Testosterone conferred cardioprotection by upregulating the cardiac alpha(1)-adrenoceptor and enhancing the effects of stimulation of this adrenoceptor. The effect of testosterone was at least partly mediated by androgen receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157169      PMCID: PMC2259204          DOI: 10.1038/sj.bjp.0707624

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  A mechanism for testosterone modulation of alpha-1 adrenergic receptor expression in the DDT1 MF-2 smooth muscle myocyte.

Authors:  M Phillippe; T Saunders; S Bangalore
Journal:  Mol Cell Biochem       Date:  1991-01-16       Impact factor: 3.396

2.  A possible role of noradrenaline in the development of myocardial infarction: an experimental study in the isolated rat heart.

Authors:  A P Waldenström; A C Hjalmarson; L Thornell
Journal:  Am Heart J       Date:  1978-01       Impact factor: 4.749

3.  Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor.

Authors:  S Wu; H Y Li; T M Wong
Journal:  Circ Res       Date:  1999-06-25       Impact factor: 17.367

Review 4.  Catecholamines in myocardial ischemia. Systemic and cardiac release.

Authors:  A Schömig
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

5.  alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes.

Authors:  E Iwai-Kanai; K Hasegawa; M Araki; T Kakita; T Morimoto; S Sasayama
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

6.  Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.

Authors:  C Gauthier; G Tavernier; J N Trochu; V Leblais; K Laurent; D Langin; D Escande; H Le Marec
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

7.  Expression of beta 3-adrenoceptor mRNA in rat tissues.

Authors:  B A Evans; M Papaioannou; V R Bonazzi; R J Summers
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Androgen receptors mediate hypertrophy in cardiac myocytes.

Authors:  J D Marsh; M H Lehmann; R H Ritchie; J K Gwathmey; G E Green; R J Schiebinger
Journal:  Circulation       Date:  1998-07-21       Impact factor: 29.690

9.  The heart is a target organ for androgen.

Authors:  H C McGill; V C Anselmo; J M Buchanan; P J Sheridan
Journal:  Science       Date:  1980-02-15       Impact factor: 47.728

10.  Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway.

Authors:  C Communal; K Singh; D R Pimentel; W S Colucci
Journal:  Circulation       Date:  1998-09-29       Impact factor: 29.690

View more
  26 in total

1.  Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy.

Authors:  Tianbao Yao; Xiaoying Ying; Yichao Zhao; Ancai Yuan; Qing He; Huan Tong; Song Ding; Junling Liu; Xu Peng; Erhe Gao; Jun Pu; Ben He
Journal:  Antioxid Redox Signal       Date:  2015-01-14       Impact factor: 8.401

2.  Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.

Authors:  O Moran; L J V Galietta; O Zegarra-Moran
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

3.  Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Authors:  Wai Ho Tang; Wing Tim Cheng; Gennadi M Kravtsov; Xiao Yong Tong; Xiu Yun Hou; Sookja K Chung; Stephen Sum Man Chung
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-23       Impact factor: 4.249

Review 4.  [Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer : Differences between GnRH antagonists and GnRH agonists].

Authors:  C Tschöpe; B Kherad; F Spillmann; C A Schneider; B Pieske; F Krackhardt
Journal:  Herz       Date:  2016-04-15       Impact factor: 1.443

5.  Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury.

Authors:  Qing He; Jun Pu; Ancai Yuan; Wayne Bond Lau; Erhe Gao; Walter J Koch; Xin-Liang Ma; Ben He
Journal:  Circ Heart Fail       Date:  2014-10-02       Impact factor: 8.790

6.  Central and peripheral testosterone effects in men with heart failure: An approach for cardiovascular research.

Authors:  Željko Bušić; Viktor Čulić
Journal:  World J Cardiol       Date:  2015-09-26

7.  Relationship of cardiac sympathetic nerve innervation and excitability to cardiac hypertrophy in very elderly male hypertensive patients.

Authors:  Shijun Li; Li Zhang; Yuanyuan Guo; Xiaoying Li
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-08-06

Review 8.  [Cardiovascular risk patients under androgen deprivation therapy: Lower risk with GnRH antagonists compared to LHRH agonists?].

Authors:  Axel S Merseburger; Daniel Sedding; Kai Hüter
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

9.  Seasonal changes in androgen receptor mRNA in the brain of the white-crowned sparrow.

Authors:  Gregory S Fraley; Robert A Steiner; Karin L Lent; Eliot A Brenowitz
Journal:  Gen Comp Endocrinol       Date:  2009-08-15       Impact factor: 2.822

Review 10.  Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications.

Authors:  B Ostadal; P Ostadal
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.